AI Article Synopsis
- The study investigates the relationship between neuropilin-2 (NRP2) expression and lymphangiogenesis in gastric carcinoma (GC).
- It involved analyzing tissue samples from 65 patients to measure NRP2 levels and lymphatic vessel density using specific antibodies.
- The findings suggest that increased NRP2 expression correlates with higher rates of lymphangiogenesis and various clinicopathological factors, indicating its potential role in GC progression and prognosis.
Article Abstract
Objective: To explore the correlation between the expression of neuropilin-2 (NRP2) and tumor-associated lymphangiogenesis and clinicopathological parameters in gastric carcinoma (GC).
Methods: All GC, margin and normal tissues of 65 cases through surgical resection were retrospectively collected at our hospital and Tangshan People's Hospital from October 2011 to October 2013. The expressions of NRP2 in GC, tumor margin and normal gastric tissues were analyzed by immunohistochemistry. Lymphangiogenesis was marked with D2-40 monoclonal antibody and microlymphatic density (MLD) counted. And the morphology of lymphatic vessels was observed.
Results: A positive expression of NRP2 was found in GC (n = 40, 61.5%) and it was significantly higher than that in tumor margin (n = 32, 49.2%) and normal tissues (n = 3, 4.6%) (P < 0.05). But the counts of MLD in both GC (12 ± 5)/mm(2) and normal region (23 ± 6)/mm(2) were significantly lower than that of tumor margin region (44 ± 13)/mm(2) (P < 0.05). In addition, the morphologies of lymphatic vessels were different among 3 groups. Also NRP2 expression and MLD count were correlated with differentiation degree, infiltrative degree, lymphatic vessel invasion, lymph node metastasis and TNM staging of GC (all P < 0.05). The expression intensity of NRP2 in tumor margin tissues was positively correlated with MLD (r = 0.517, P = 0.000).
Conclusions: The expression of NRP2 in GC may modulate lymphangiogenesis and lymphatic metastasis. And it may play a key role in tumorigenesis, progression and prognosis predicating in GC.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Imiquimod Cream Preceded by Superficial Curettage vs Surgical Excision for Nodular Basal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Dermatol
January 2025
Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Background: Interest in noninvasive treatment of basal cell carcinoma (BCC) has been increasing. For superficial BCC, it has been demonstrated that imiquimod cream, 5%, has high long-term efficacy, but for nodular BCC (nBCC), long-term evidence is sparse.
Objectives: To evaluate whether superficial curettage (SC) followed by imiquimod cream, 5%, is noninferior to surgical excision (SE) in nBCC after 5 years of treatment.
Bright and Specific Targeting of Metastatic Lymph Nodes in Orthotopic Mouse Models of Gastric Cancer with a Fluorescent Anti-CEA Antibody.
Ann Surg Oncol
January 2025
Department of Surgery, University of California San Diego, La Jolla, CA, USA.
Background: Gastric cancer poses a major diagnostic and therapeutic challenge. Improved visualization of tumor margins and lymph node metastases with tumor-specific fluorescent markers could improve outcomes.
Methods: To establish orthotopic models of gastric cancer, one million cells of the human gastric cancer cell line, MKN45, were suspended in 50 μl of equal parts PBS and Matrigel and injected into the nude mouse stomach with a 29-gauge needle.
Long-Term Outcomes of Jugular Paragangliomas Undergoing Gamma Knife Radiosurgery: A Single Center Experience.
Neurosurgery
January 2025
Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Background And Objectives: Jugular paragangliomas (JPG) pose a surgical challenge because of their vascularity and complex location. Stereotactic radiosurgery (SRS) offers a minimally invasive management for patients with JPG. Our aim was to evaluate outcomes of Gamma Knife radiosurgery (GKRS) for the treatment of JPG over the long term.
View Article and Find Full Text PDFComparison of the efficacy of neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients: meta-analysis of randomized controlled trials.
Int J Surg
January 2025
Department of Gastrointestinal Surgery, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, Sichuan Province, China.
Background: Preoperative neoadjuvant chemoradiotherapy (nCRT) is considered to be the standard treatment strategy for locally advanced rectal cancer (LARC); however, the risk of adverse events and postoperative recurrence remains significant. This study aimed to evaluate the non-inferiority of neoadjuvant chemotherapy (nCT) compared with nCRT in patients with LARC and to assess the possibility of eliminating radiotherapy on the basis of guaranteed efficacy.
Materials And Methods: We searched the PubMed, Embase, and Cochrane Library databases to identify randomized controlled trials (RCTs) comparing the efficacy of nCRT and nCT for LARC.
Objective: Transrectal (TR) prostate biopsy is being increasingly abandoned in favour of a transperineal (TP) approach as well as a targeted biopsy only of the index lesion(s). It remains underreported how these changes could impact concordance at final pathology. We aimed to evaluate the impact of transitioning from standard transrectal (sTR) to cognitive targeted transperineal (cog-tTP) biopsy on final pathology including concordance and upgrading.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!